500 Mg Rituximab Injection

Name: 500 Mg Rituximab Injection
Brand: NEETCO BIOPHARMA
Price: 2000 INR
Availability: InStock

Price 2000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

500 Mg Rituximab Injection Specification

Dosage Form
Injection

Indication
Non-Hodgkins lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with polyangiitis, Microscopic polyangiitis

Salt Composition
Rituximab 500 mg

Enzyme Types
Not applicable (Monoclonal antibody, not an enzyme)

Feature
Chimeric monoclonal antibody; targets CD20 antigen on B-lymphocytes

Ingredients
Rituximab, excipients, sterile water for injection

Application
IV administration in oncology and autoimmune disorders

Ph Level
pH 6.5 to 7.0 (in reconstituted solution)

Physical Color/Texture
Clear to slightly opalescent, colorless to pale yellow liquid

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C. Do not freeze. Protect from light.

Shelf Life
24 months from the date of manufacture

Contraindications
Hypersensitivity to rituximab or murine proteins

Brand Name
Reditux / Mabthera / (Brand may vary)

Diluent
0.9% Sodium Chloride Injection

Packaging Type
Single-use vial

Administration Route
Intravenous infusion

Prescription
Prescription only (Rx)

Strength
500 mg/50 mL vial

Usage
Must be administered under medical supervision

About 500 Mg Rituximab Injection

Experience a first-rate solution for complex oncology and autoimmune conditions with Top-quality 500 Mg Rituximab Injection. Featured under select brands such as Reditux and Mabthera, this valuable monoclonal antibody comes in a single-use vial and is exclusively for intravenous infusion. Highly regarded for its noble role in targeting CD20 on B-lymphocytes, it is a preferred deal for healthcare professionals treating Non-Hodgkin's lymphoma, Chronic Lymphocytic Leukemia, and autoimmune disorders. Delivered in a clear to slightly opalescent liquid, the injectable must be administered under expert supervision, ensuring first-class patient safety and efficacy. Storage at 2-8C safeguards its elite performance.

Key Features & Application of 500 Mg Rituximab Injection

The 500 Mg Rituximab Injection is designed for intravenous use under professional medical supervision. Its material feature as a chimeric monoclonal antibody makes it particularly effective in treating various oncology and autoimmune disorders, including lymphoma, leukemia, and certain vasculitides. The application requires careful IV administration, and its physical characteristics-clear to slightly opalescent and colorless to pale yellow-ensure optimal handling. This first-rate injection is strictly prescription-based, ensuring its selective use for noble diagnostic and therapeutic purposes.

Sample Policy, Delivery, and Supply Details

Sample policies for 500 Mg Rituximab Injection are structured to meet diverse client needs, ensuring samples may be delivered according to regulatory guidelines. With supply ability tailored to demand, customers can expect goods transport through accredited channels, originating from top distributors and exporters in India. We guarantee safe delivery at the lowest price possible, utilizing reliable FOB ports for international orders. Our logistics promise the valuable product will arrive on time, maintaining the cold chain for exceptional quality.

FAQ's of 500 Mg Rituximab Injection:

Q: How is 500 Mg Rituximab Injection administered?

A: 500 Mg Rituximab Injection is administered through intravenous infusion under strict medical supervision. It must be diluted with 0.9% Sodium Chloride Injection and given slowly to minimize infusion-related reactions.

Q: What are the main conditions treated with this injection?

A: This injection is primarily used to manage Non-Hodgkin's lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with polyangiitis, and Microscopic polyangiitis, making it a valuable option for various oncology and autoimmune conditions.

Q: When is it contraindicated to use Rituximab Injection?

A: Rituximab Injection is contraindicated in individuals with known hypersensitivity to rituximab or murine proteins. It should not be used if the patient has experienced severe reactions to similar biologic medicines in the past.

Q: What benefits does 500 Mg Rituximab Injection offer in clinical practice?

A: Being a targeted therapy, Rituximab selectively attacks CD20 antigens on B-lymphocytes, providing first-rate disease control with minimized impact on other cells, leading to a noble and valuable therapeutic option in specific medical settings.

Q: How should the 500 Mg Rituximab Injection be stored before administration?

A: The injection must be kept at 2C to 8C, protected from light, and never frozen. Proper storage ensures its stability and efficacy for up to 24 months from the date of manufacture.

Tell us about your requirement